LC/MS, MALDI, LC/TOF
IndustriesPharma & Biopharma
ManufacturerShimadzu
Importance of the Topic
Oligonucleotide therapeutics require rapid and reliable analytical methods for molecular weight and sequence confirmation. The MALDImini-1 digital ion trap mass spectrometer in conjunction with LabSolutions Insight Biologics software addresses the growing demand for compact, high-throughput platforms in oligonucleotide research and quality control.
Objectives and Study Overview
This study demonstrates a workflow for swift oligonucleotide sequence analysis using a synthetic 18-mer model (nusinersen analogue). The goal is to deliver both molecular weight determination and base sequence assignment in approximately ten minutes, leveraging the compact MALDI-DIT-MS system and dedicated software.
Methodology and Instrumentation
- Instrument: MALDImini-1 MALDI digital ion trap mass spectrometer
- Software: LabSolutions Insight Biologics
- Sample: 20 pmol/µL 18-mer oligonucleotide with 2'-O-methoxyethyl and methyl modifications and phosphorothioate backbone
- Matrix: 3-hydroxypicolinic acid and 2,4-dihydroxyacetophenone mixture (1:1 in acetonitrile/water with diammonium hydrogen citrate)
- Sample preparation: Matrix/sample mixed 1:1 v/v, 1 µL spotted and air-dried
- Acquisition settings: MW analysis (LP 60–65 V, DV-1 1300 V, DV-2 7000 V, RF delay 25 ms); Sequence analysis (LP 65–75 V, DV-1 1600 V, DV-2 8000 V, RF delay 15–17 ms; scan ranges m/z 650–5000 and 2000–18000)
- Data output: mzML files imported into the software, theoretical sequence entered, and automated identification performed
Key Results and Discussion
- MW analysis: A prominent [M+H]+ peak at m/z ~7127 matched the theoretical mass with minimal background.
- Sequence analysis: Specific cleavage of the phosphodiester backbone yielded clean, singly charged fragment ions that simplify coverage mapping.
- Software integration: Automatic merging of spectra, immediate fragment assignment, and clear visualization of sequence coverage enhance throughput and data confidence.
Benefits and Practical Applications
- Compact footprint suitable for space-limited labs and powered by a standard 100 V supply
- Rapid end-to-end workflow (~10 min) from sample prep to final report
- Streamlined data interpretation through restricted ion species and user-friendly interface
- Ideal for quality control and R&D of therapeutic oligonucleotides
Future Trends and Opportunities
Advances may include expanded analyte scope to longer or heavily modified oligonucleotides, integration with liquid chromatography for complex mixtures, and improved algorithms for real-time data processing.
- Automated high-throughput sample handling and plate automation
- Enhanced software workflows for novel modifications and isomer differentiation
- Coupling with separation techniques to resolve isobaric species
- Applications in mRNA vaccine QA, CRISPR guide RNA verification, and aptamer screening
Conclusion
The MALDImini-1 and LabSolutions Insight Biologics platform offers a fast, reliable, and compact solution for oligonucleotide mass and sequence analysis, fulfilling the needs of modern therapeutic development and quality assurance laboratories.
Reference
- Fukuyama Y., Uchiyama K., Nishikaze T. Application Note 01-00875-EN, Shimadzu Corporation, Apr. 2025
- Shimadzu Application News 01-00594-EN
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.